We analyzed catalase (CAT), glutathione (GSH), malondialdehyde (MDA), superoxide dismutase (SOD) activity (as oxidative markers) and also MMP-9 and TNF-α level in the plasma of patients with opioid use disorder during two weeks of methadone therapy. Here, MMP9 is linked to opioid use disorder.